Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Early-Life Genetic Risk for Multiple Sclerosis Shapes T Cell Composition in Childhood
Genetics
Early-Life Genetic Risk for Multiple Sclerosis Shapes T Cell Composition in Childhood

29, Jan 2026

2
Early-Life Genetic Risk for Multiple Sclerosis Shapes T Cell Composition in Childhood
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort

28, Jan 2026

3
Role of Rare Genetic Variants in Multiple Sclerosis Pathogenesis
Genetics
Role of Rare Genetic Variants in Multiple Sclerosis Pathogenesis

27, Jan 2026

4
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis
Genetics
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis

26, Jan 2026

5
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk

25, Jan 2026

Categories:
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis

27, Aug 2025

Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology
Genetics
Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology

28, Aug 2025